路透10月23日 - Staar Surgical STAA.O周四表示，该公司已将对瑞士眼科巨头爱尔康ALCC.S15亿美元收购要约的股东投票推迟到11月6日。
推迟投票的原因是Staar董事会与主要投资者之间的对立运动，其中以持有27.5%股份的Broadwood Partners公司为首。反对股东认为， (link)，该交易低估了企业价值，反映出出售过程存在缺陷。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.